{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:19:59Z","timestamp":1788542399500,"version":"build-2803163510"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,9,25]]},"DOI":"10.7759\/cureus.70148","type":"journal-article","created":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T13:03:33Z","timestamp":1727269413000},"source":"Crossref","is-referenced-by-count":6,"title":["Shared Pathophysiology of Inflammatory Bowel Disease and Psoriasis: Unraveling the Connection"],"prefix":"10.7759","author":[{"given":"Shadi","family":"Tabbarah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakam","family":"Sulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Ansah Owusu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megha","family":"Rajeev Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitheesha Reddy","family":"Marepalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nohelia","family":"Pino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samra","family":"Saleem Azam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaliya","family":"Ali Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Abraham Su\u00e1rez \u00c1lvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1177\/17562848221142673","article-title":"A scoping review on early inflammatory bowel disease: definitions, pathogenesis, and impact on clinical outcomes","volume":"15","author":"Estevinho MM","year":"2022","unstructured":"Estevinho MM, Le\u00e3o Moreira P, Silva I, Laranjeira Correia J, Santiago M, Magro F. A scoping review on early inflammatory bowel disease: definitions, pathogenesis, and impact on clinical outcomes. Therap Adv Gastroenterol. 2022, 15:17562848221142673. 10.1177\/17562848221142673","journal-title":"Therap Adv Gastroenterol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.25122\/jml-2018-0075","article-title":"A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease","volume":"12","author":"Seyedian SS","year":"2019","unstructured":"Seyedian SS, Nokhostin F, Malamir MD. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease. J Med Life. 2019, 12:113-22. 10.25122\/jml-2018-0075","journal-title":"J Med Life"},{"key":"ref3","doi-asserted-by":"crossref","DOI":"10.1016\/S0016-5085(75)80270-8","article-title":"Clinical patterns in Crohn's disease: a statistical study of 615 cases","volume":"68","author":"Farmer RG","year":"1975","unstructured":"Farmer RG, Hawk WA, Turnbull RB Jr. Clinical patterns in Crohn's disease: a statistical study of 615 cases. Gastroenterology. 1975, 68:627-35.","journal-title":"Gastroenterology"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2021-0257","article-title":"Psoriasis: a brief overview","volume":"21","author":"Raharja A","year":"2021","unstructured":"Raharja A, Mahil SK, Barker JN. Psoriasis: a brief overview. Clin Med (Lond). 2021, 21:170-3. 10.7861\/clinmed.2021-0257","journal-title":"Clin Med (Lond)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.4006","article-title":"Pathophysiology, clinical presentation, and treatment of psoriasis: a review","volume":"323","author":"Armstrong AW","year":"2020","unstructured":"Armstrong AW, Read C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA. 2020, 323:1945-60. 10.1001\/jama.2020.4006","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000500116","article-title":"Psoriasis and inflammatory bowel disease","volume":"37","author":"Cottone M","year":"2019","unstructured":"Cottone M, Sapienza C, Macaluso FS, Cannizzaro M. Psoriasis and inflammatory bowel disease. Dig Dis. 2019, 37:451-7. 10.1159\/000500116","journal-title":"Dig Dis"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2013.06.004","article-title":"Innate and adaptive immunity in inflammatory bowel disease","volume":"13","author":"Geremia A","year":"2014","unstructured":"Geremia A, Biancheri P, Allan P, Corazza GR, Di Sabatino A. Innate and adaptive immunity in inflammatory bowel disease. Autoimmun Rev. 2014, 13:3-10. 10.1016\/j.autrev.2013.06.004","journal-title":"Autoimmun Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/983902","article-title":"Correlations between psoriasis and inflammatory bowel diseases","volume":"2013","author":"Skroza N","year":"2013","unstructured":"Skroza N, Proietti I, Pampena R, et al.. Correlations between psoriasis and inflammatory bowel diseases. Biomed Res Int. 2013, 2013:983902. 10.1155\/2013\/983902","journal-title":"Biomed Res Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz152","article-title":"Global prevalence and bidirectional association between psoriasis and inflammatory bowel disease-a systematic review and meta-analysis","volume":"14","author":"Alinaghi F","year":"2020","unstructured":"Alinaghi F, Tekin HG, Burisch J, Wu JJ, Thyssen JP, Egeberg A. Global prevalence and bidirectional association between psoriasis and inflammatory bowel disease-a systematic review and meta-analysis. J Crohns Colitis. 2020, 14:351-60. 10.1093\/ecco-jcc\/jjz152","journal-title":"J Crohns Colitis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.5455\/annalsmedres.2019.02.174","article-title":"Skin and gut: psoriasis and irritable bowel syndrome. Is there an association?","volume":"27","author":"Urun Unal G","year":"2020","unstructured":"Urun Unal G, Marakoglu K, Eryilmaz MA, Unal M, Kulahci O. Skin and gut: psoriasis and irritable bowel syndrome. Is there an association?. Ann Med Res. 2020, 27:1611-5. 10.5455\/annalsmedres.2019.02.174","journal-title":"Ann Med Res"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.880201","article-title":"Epidemiology of psoriasis and comorbid diseases: a narrative review","volume":"13","author":"Bu J","year":"2022","unstructured":"Bu J, Ding R, Zhou L, Chen X, Shen E. Epidemiology of psoriasis and comorbid diseases: a narrative review. Front Immunol. 2022, 13:880201. 10.3389\/fimmu.2022.880201","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.3631","article-title":"Association of psoriasis with inflammatory bowel disease: a systematic review and meta-analysis","volume":"154","author":"Fu Y","year":"2018","unstructured":"Fu Y, Lee CH, Chi CC. Association of psoriasis with inflammatory bowel disease: a systematic review and meta-analysis. JAMA Dermatol. 2018, 154:1417-23. 10.1001\/jamadermatol.2018.3631","journal-title":"JAMA Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.07.029","article-title":"Incidence and risk of inflammatory bowel disease in patients with psoriasis-a nationwide 20-year cohort study","volume":"139","author":"Egeberg A","year":"2019","unstructured":"Egeberg A, Thyssen JP, Burisch J, Colombel JF. Incidence and risk of inflammatory bowel disease in patients with psoriasis-a nationwide 20-year cohort study. J Invest Dermatol. 2019, 139:316-23. 10.1016\/j.jid.2018.07.029","journal-title":"J Invest Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2003.540","article-title":"Connections between psoriasis and Crohn's disease","volume":"48","author":"Najarian DJ","year":"2003","unstructured":"Najarian DJ, Gottlieb AB. Connections between psoriasis and Crohn's disease. J Am Acad Dermatol. 2003, 48:805-21; quiz 822-4. 10.1067\/mjd.2003.540","journal-title":"J Am Acad Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s40291-023-00678-7","article-title":"The genetics of inflammatory bowel disease","volume":"28","author":"El Hadad J","year":"2024","unstructured":"El Hadad J, Schreiner P, Vavricka SR, Greuter T. The genetics of inflammatory bowel disease. Mol Diagn Ther. 2024, 28:27-35. 10.1007\/s40291-023-00678-7","journal-title":"Mol Diagn Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14868","article-title":"Shifting the focus - the primary role of IL-23 in psoriasis and other inflammatory disorders","volume":"32","author":"Gooderham MJ","year":"2018","unstructured":"Gooderham MJ, Papp KA, Lynde CW. Shifting the focus - the primary role of IL-23 in psoriasis and other inflammatory disorders. J Eur Acad Dermatol Venereol. 2018, 32:1111-9. 10.1111\/jdv.14868","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010171","article-title":"Psoriasis: a STAT3-centric view","volume":"19","author":"Calautti E","year":"2018","unstructured":"Calautti E, Avalle L, Poli V. Psoriasis: a STAT3-centric view. Int J Mol Sci. 2018, 19:171. 10.3390\/ijms19010171","journal-title":"Int J Mol Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8010115","article-title":"Familial aggregation of psoriasis and co-aggregation of autoimmune diseases in affected families","volume":"8","author":"Huang YH","year":"2019","unstructured":"Huang YH, Kuo CF, Huang LH, Hsieh MY. Familial aggregation of psoriasis and co-aggregation of autoimmune diseases in affected families. J Clin Med. 2019, 8:115. 10.3390\/jcm8010115","journal-title":"J Clin Med"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.5217\/ir.2017.15.3.388","article-title":"Familial aggregation of inflammatory bowel disease in patients with ulcerative colitis","volume":"15","author":"Gupta A","year":"2017","unstructured":"Gupta A, Bopanna S, Kedia S, et al.. Familial aggregation of inflammatory bowel disease in patients with ulcerative colitis. Intest Res. 2017, 15:388-94. 10.5217\/ir.2017.15.3.388","journal-title":"Intest Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv068","article-title":"Psoriasis phenotype in inflammatory bowel disease: a case-control prospective study","volume":"9","author":"Lolli E","year":"2015","unstructured":"Lolli E, Saraceno R, Calabrese E, et al.. Psoriasis phenotype in inflammatory bowel disease: a case-control prospective study. J Crohns Colitis. 2015, 9:699-707. 10.1093\/ecco-jcc\/jjv068","journal-title":"J Crohns Colitis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cytogfr.2007.10.004","article-title":"Dendritic cells and cytokines in human inflammatory and autoimmune diseases","volume":"19","author":"Blanco P","year":"2008","unstructured":"Blanco P, Palucka AK, Pascual V, Banchereau J. Dendritic cells and cytokines in human inflammatory and autoimmune diseases. Cytokine Growth Factor Rev. 2008, 19:41-52. 10.1016\/j.cytogfr.2007.10.004","journal-title":"Cytokine Growth Factor Rev"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2014.12.014","article-title":"Genetic and epigenetic basis of psoriasis pathogenesis","volume":"64","author":"Chandra A","year":"2015","unstructured":"Chandra A, Ray A, Senapati S, Chatterjee R. Genetic and epigenetic basis of psoriasis pathogenesis. Mol Immunol. 2015, 64:313-23. 10.1016\/j.molimm.2014.12.014","journal-title":"Mol Immunol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.12736","article-title":"Immunohistochemical expression of VDR is associated with reduced integrity of tight junction complex in psoriatic skin","volume":"29","author":"Visconti B","year":"2015","unstructured":"Visconti B, Paolino G, Carotti S, Pendolino AL, Morini S, Richetta AG, Calvieri S. Immunohistochemical expression of VDR is associated with reduced integrity of tight junction complex in psoriatic skin. J Eur Acad Dermatol Venereol. 2015, 29:2038-42. 10.1111\/jdv.12736","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-43899-9","article-title":"Th1, Th17, and Treg responses are differently modulated by TNF-\u03b1 inhibitors and methotrexate in psoriasis patients","volume":"9","author":"Furiati SC","year":"2019","unstructured":"Furiati SC, Catarino JS, Silva MV, et al.. Th1, Th17, and Treg responses are differently modulated by TNF-\u03b1 inhibitors and methotrexate in psoriasis patients. Sci Rep. 2019, 9:7526. 10.1038\/s41598-019-43899-9","journal-title":"Sci Rep"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-011-1169-1","article-title":"Innate immunity in the pathogenesis of psoriasis","volume":"303","author":"Sweeney CM","year":"2011","unstructured":"Sweeney CM, Tobin AM, Kirby B. Innate immunity in the pathogenesis of psoriasis. Arch Dermatol Res. 2011, 303:691-705. 10.1007\/s00403-011-1169-1","journal-title":"Arch Dermatol Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics","volume":"22","author":"Jang DI","year":"2021","unstructured":"Jang DI, Lee AH, Shin HY, et al.. The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics. Int J Mol Sci. 2021, 22:2719. 10.3390\/ijms22052719","journal-title":"Int J Mol Sci"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14433","article-title":"The role of IL-23 and the IL-23\/TH 17 immune axis in the pathogenesis and treatment of psoriasis","volume":"31","author":"Girolomoni G","year":"2017","unstructured":"Girolomoni G, Strohal R, Puig L, Bachelez H, Barker J, Boehncke WH, Prinz JC. The role of IL-23 and the IL-23\/TH 17 immune axis in the pathogenesis and treatment of psoriasis. J Eur Acad Dermatol Venereol. 2017, 31:1616-26. 10.1111\/jdv.14433","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-032713-120225","article-title":"Immunology of psoriasis","volume":"32","author":"Lowes MA","year":"2014","unstructured":"Lowes MA, Su\u00e1rez-Fari\u00f1as M, Krueger JG. Immunology of psoriasis. Annu Rev Immunol. 2014, 32:227-55. 10.1146\/annurev-immunol-032713-120225","journal-title":"Annu Rev Immunol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/s0001-7310(09)73372-1","article-title":"Progress in understanding the immunopathogenesis of psoriasis","volume":"100","author":"Mak RK","year":"2009","unstructured":"Mak RK, Hundhausen C, Nestle FO. Progress in understanding the immunopathogenesis of psoriasis. Actas Dermosifiliogr. 2009, 100:2-13. 10.1016\/s0001-7310(09)73372-1","journal-title":"Actas Dermosifiliogr"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1126\/science.1135245","article-title":"A genome-wide association study identifies IL23R as an inflammatory bowel disease gene","volume":"314","author":"Duerr RH","year":"2006","unstructured":"Duerr RH, Taylor KD, Brant SR, et al.. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006, 314:1461-3. 10.1126\/science.1135245","journal-title":"Science"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1615\/critrevimmunol.v32.i1.30","article-title":"Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease","volume":"32","author":"Iyer SS","year":"2012","unstructured":"Iyer SS, Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol. 2012, 32:23-63. 10.1615\/critrevimmunol.v32.i1.30","journal-title":"Crit Rev Immunol"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2020.1836313","article-title":"Spotlight on the treatment armamentarium of concomitant psoriasis and inflammatory bowel disease: a systematic review","volume":"33","author":"Conforti C","year":"2022","unstructured":"Conforti C, Dianzani C, Zalaudek I, et al.. Spotlight on the treatment armamentarium of concomitant psoriasis and inflammatory bowel disease: a systematic review. J Dermatolog Treat. 2022, 33:1279-86. 10.1080\/09546634.2020.1836313","journal-title":"J Dermatolog Treat"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1111\/bph.12722","article-title":"Immunosuppressive and anti-inflammatory properties of engineered nanomaterials","volume":"171","author":"Ilinskaya AN","year":"2014","unstructured":"Ilinskaya AN, Dobrovolskaia MA. Immunosuppressive and anti-inflammatory properties of engineered nanomaterials. Br J Pharmacol. 2014, 171:3988-4000. 10.1111\/bph.12722","journal-title":"Br J Pharmacol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.4292\/wjgpt.v7.i1.112","article-title":"Influence of environmental factors in the development of inflammatory bowel diseases","volume":"7","author":"Legaki E","year":"2016","unstructured":"Legaki E, Gazouli M. Influence of environmental factors in the development of inflammatory bowel diseases. World J Gastrointest Pharmacol Ther. 2016, 7:112-25. 10.4292\/wjgpt.v7.i1.112","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2010.252","article-title":"The inflammatory bowel diseases and ambient air pollution: a novel association","volume":"105","author":"Kaplan GG","year":"2010","unstructured":"Kaplan GG, Hubbard J, Korzenik J, et al.. The inflammatory bowel diseases and ambient air pollution: a novel association. Am J Gastroenterol. 2010, 105:2412-9. 10.1038\/ajg.2010.252","journal-title":"Am J Gastroenterol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2011.44","article-title":"Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature","volume":"106","author":"Hou JK","year":"2011","unstructured":"Hou JK, Abraham B, El-Serag H. Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature. Am J Gastroenterol. 2011, 106:563-73. 10.1038\/ajg.2011.44","journal-title":"Am J Gastroenterol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2011.04784.x","article-title":"Aspirin in the aetiology of Crohn's disease and ulcerative colitis: a European prospective cohort study","volume":"34","author":"Chan SS","year":"2011","unstructured":"Chan SS, Luben R, Bergmann MM, et al.. Aspirin in the aetiology of Crohn's disease and ulcerative colitis: a European prospective cohort study. Aliment Pharmacol Ther. 2011, 34:649-55. 10.1111\/j.1365-2036.2011.04784.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2022.3682","article-title":"Association between inflammatory bowel disease and both psoriasis and psoriatic arthritis: a bidirectional 2-sample Mendelian randomization study","volume":"158","author":"Freuer D","year":"2022","unstructured":"Freuer D, Linseisen J, Meisinger C. Association between inflammatory bowel disease and both psoriasis and psoriatic arthritis: a bidirectional 2-sample Mendelian randomization study. JAMA Dermatol. 2022, 158:1262-8. 10.1001\/jamadermatol.2022.3682","journal-title":"JAMA Dermatol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24054901","article-title":"Psoriatic arthritis: pathogenesis and targeted therapies","volume":"24","author":"Azuaga AB","year":"2023","unstructured":"Azuaga AB, Ram\u00edrez J, Ca\u00f1ete JD. Psoriatic arthritis: pathogenesis and targeted therapies. Int J Mol Sci. 2023, 24:4901. 10.3390\/ijms24054901","journal-title":"Int J Mol Sci"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms9020353","article-title":"Gut-skin axis: current knowledge of the interrelationship between microbial dysbiosis and skin conditions","volume":"9","author":"De Pessemier B","year":"2021","unstructured":"De Pessemier B, Grine L, Debaere M, Maes A, Paetzold B, Callewaert C. Gut-skin axis: current knowledge of the interrelationship between microbial dysbiosis and skin conditions. Microorganisms. 2021, 9:353. 10.3390\/microorganisms9020353","journal-title":"Microorganisms"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10051037","article-title":"Gut-skin axis: unravelling the connection between the gut microbiome and psoriasis","volume":"10","author":"Thye AY","year":"2022","unstructured":"Thye AY, Bah YR, Law JW, et al.. Gut-skin axis: unravelling the connection between the gut microbiome and psoriasis. Biomedicines. 2022, 10:1037. 10.3390\/biomedicines10051037","journal-title":"Biomedicines"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318427","article-title":"Leaky gut: mechanisms, measurement and clinical implications in humans","volume":"68","author":"Camilleri M","year":"2019","unstructured":"Camilleri M. Leaky gut: mechanisms, measurement and clinical implications in humans. Gut. 2019, 68:1516-26. 10.1136\/gutjnl-2019-318427","journal-title":"Gut"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjac034","article-title":"Interleukin-23 in the pathogenesis of inflammatory bowel disease and implications for therapeutic intervention","volume":"16","author":"Sewell GW","year":"2022","unstructured":"Sewell GW, Kaser A. Interleukin-23 in the pathogenesis of inflammatory bowel disease and implications for therapeutic intervention. J Crohns Colitis. 2022, 16:ii3-19. 10.1093\/ecco-jcc\/jjac034","journal-title":"J Crohns Colitis"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2008.080088","article-title":"Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis","volume":"173","author":"Elias PM","year":"2008","unstructured":"Elias PM, Arbiser J, Brown BE, et al.. Epidermal vascular endothelial growth factor production is required for permeability barrier homeostasis, dermal angiogenesis, and the development of epidermal hyperplasia: implications for the pathogenesis of psoriasis. Am J Pathol. 2008, 173:689-99. 10.2353\/ajpath.2008.080088","journal-title":"Am J Pathol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1097\/01.MIB.0000436959.62286.f9","article-title":"Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy","volume":"20","author":"Marzano AV","year":"2014","unstructured":"Marzano AV, Borghi A, Stadnicki A, Crosti C, Cugno M. Cutaneous manifestations in patients with inflammatory bowel diseases: pathophysiology, clinical features, and therapy. Inflamm Bowel Dis. 2014, 20:213-27. 10.1097\/01.MIB.0000436959.62286.f9","journal-title":"Inflamm Bowel Dis"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.2147\/PTT.S85194","article-title":"Psoriasis and inflammatory bowel disease: links and risks","volume":"6","author":"Vlachos C","year":"2016","unstructured":"Vlachos C, Gaitanis G, Katsanos KH, Christodoulou DK, Tsianos E, Bassukas ID. Psoriasis and inflammatory bowel disease: links and risks. Psoriasis (Auckl). 2016, 6:73-92. 10.2147\/PTT.S85194","journal-title":"Psoriasis (Auckl)"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13282","article-title":"Inflammatory bowel disease and psoriasis: modernizing the multidisciplinary approach","volume":"290","author":"Hedin CR","year":"2021","unstructured":"Hedin CR, Sonkoly E, Eberhardson M, St\u00e5hle M. Inflammatory bowel disease and psoriasis: modernizing the multidisciplinary approach. J Intern Med. 2021, 290:257-78. 10.1111\/joim.13282","journal-title":"J Intern Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10769-x","article-title":"Conserved transcriptomic profile between mouse and human colitis allows unsupervised patient stratification","volume":"10","author":"Czarnewski P","year":"2019","unstructured":"Czarnewski P, Parigi SM, Sorini C, Diaz OE, Das S, Gagliani N, Villablanca EJ. Conserved transcriptomic profile between mouse and human colitis allows unsupervised patient stratification. Nat Commun. 2019, 10:2892. 10.1038\/s41467-019-10769-x","journal-title":"Nat Commun"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59255","article-title":"Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis","volume":"121","author":"Lee JC","year":"2011","unstructured":"Lee JC, Lyons PA, McKinney EF, et al.. Gene expression profiling of CD8+ T cells predicts prognosis in patients with Crohn disease and ulcerative colitis. J Clin Invest. 2011, 121:4170-9. 10.1172\/JCI59255","journal-title":"J Clin Invest"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-318343","article-title":"A blood-based prognostic biomarker in IBD","volume":"68","author":"Biasci D","year":"2019","unstructured":"Biasci D, Lee JC, Noor NM, et al.. A blood-based prognostic biomarker in IBD. Gut. 2019, 68:1386-95. 10.1136\/gutjnl-2019-318343","journal-title":"Gut"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.14979","article-title":"Secukinumab treatment in new-onset psoriasis: aiming to understand the potential for disease modification - rationale and design of the randomized, multicenter STEPIn study","volume":"32","author":"Iversen L","year":"2018","unstructured":"Iversen L, Eidsmo L, Austad J, et al.. Secukinumab treatment in new-onset psoriasis: aiming to understand the potential for disease modification - rationale and design of the randomized, multicenter STEPIn study. J Eur Acad Dermatol Venereol. 2018, 32:1930-9. 10.1111\/jdv.14979","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2016.1112739","article-title":"Interleukin 17-A inhibition in the treatment of psoriasis","volume":"12","author":"Yiu ZZ","year":"2016","unstructured":"Yiu ZZ, Griffiths CE. Interleukin 17-A inhibition in the treatment of psoriasis. Expert Rev Clin Immunol. 2016, 12:1-4. 10.1586\/1744666X.2016.1112739","journal-title":"Expert Rev Clin Immunol"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1172\/JCI21404","article-title":"IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6","volume":"116","author":"Yen D","year":"2006","unstructured":"Yen D, Cheung J, Scheerens H, et al.. IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J Clin Invest. 2006, 116:1310-6. 10.1172\/JCI21404","journal-title":"J Clin Invest"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15082171","article-title":"An insight on the possible association between inflammatory bowel disease and biologic therapy with IL-17 inhibitors in psoriasis patients","volume":"15","author":"Orzan OA","year":"2023","unstructured":"Orzan OA, \u021aieranu CG, Olteanu AO, et al.. An insight on the possible association between inflammatory bowel disease and biologic therapy with IL-17 inhibitors in psoriasis patients. Pharmaceutics. 2023, 15:2171. 10.3390\/pharmaceutics15082171","journal-title":"Pharmaceutics"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12437","article-title":"Psoriasis: to treat or to manage?","volume":"23","author":"Mrowietz U","year":"2014","unstructured":"Mrowietz U, Steinz K, Gerdes S. Psoriasis: to treat or to manage?. Exp Dermatol. 2014, 23:705-9. 10.1111\/exd.12437","journal-title":"Exp Dermatol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10061311","article-title":"The temporal relationships and associations between cutaneous manifestations and inflammatory bowel disease: a nationwide population-based cohort study","volume":"10","author":"Hung YT","year":"2021","unstructured":"Hung YT, Le PH, Kuo CJ, et al.. The temporal relationships and associations between cutaneous manifestations and inflammatory bowel disease: a nationwide population-based cohort study. J Clin Med. 2021, 10:1311. 10.3390\/jcm10061311","journal-title":"J Clin Med"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1136\/egastro-2023-100012","article-title":"Horizon scanning: new and future therapies in the management of inflammatory bowel disease","volume":"1","author":"Kumar A","year":"2023","unstructured":"Kumar A, Smith PJ. Horizon scanning: new and future therapies in the management of inflammatory bowel disease. eGastroenterology. 2023, 1:e100012. 10.1136\/egastro-2023-100012","journal-title":"eGastroenterology"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1900750","article-title":"Ustekinumab as induction and maintenance therapy for ulcerative colitis","volume":"381","author":"Sands BE","year":"2019","unstructured":"Sands BE, Sandborn WJ, Panaccione R, et al.. Ustekinumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2019, 381:1201-14. 10.1056\/NEJMoa1900750","journal-title":"N Engl J Med"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.817100","article-title":"Neurotransmitter and intestinal interactions: focus on the microbiota-gut-brain axis in irritable bowel syndrome","volume":"13","author":"Chen M","year":"2022","unstructured":"Chen M, Ruan G, Chen L, et al.. Neurotransmitter and intestinal interactions: focus on the microbiota-gut-brain axis in irritable bowel syndrome. Front Endocrinol (Lausanne). 2022, 13:817100. 10.3389\/fendo.2022.817100","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/282306-shared-pathophysiology-of-inflammatory-bowel-disease-and-psoriasis-unraveling-the-connection","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,25]],"date-time":"2024-09-25T13:03:35Z","timestamp":1727269415000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/282306-shared-pathophysiology-of-inflammatory-bowel-disease-and-psoriasis-unraveling-the-connection"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,25]]},"references-count":59,"URL":"https:\/\/doi.org\/10.7759\/cureus.70148","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,25]]}}}